3-(IMIDAZOL-4-YL)PROPIONIC ACID

CAS No. 1074-59-5

3-(IMIDAZOL-4-YL)PROPIONIC ACID ( SALOR-INT L480258-1EA; Deamino-histidine; Imidazolylpropionic acid )

Catalog No. M28714 CAS No. 1074-59-5

3-(IMIDAZOL-4-YL)PROPIONIC ACID is a product of histidine metabolism and may involve oxidation or transamination.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 35 In Stock
100MG 58 In Stock
500MG 138 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    3-(IMIDAZOL-4-YL)PROPIONIC ACID
  • Note
    Research use only, not for human use.
  • Brief Description
    3-(IMIDAZOL-4-YL)PROPIONIC ACID is a product of histidine metabolism and may involve oxidation or transamination.
  • Description
    3-(IMIDAZOL-4-YL)PROPIONIC ACID is a product of histidine metabolism and may involve oxidation or transamination. 3-(IMIDAZOL-4-YL)PROPIONIC ACID is potent inhibitors of G. candidum histidinol dehydrogenase, showing IC50 values as low as 3.17 microM.
  • Synonyms
    SALOR-INT L480258-1EA; Deamino-histidine; Imidazolylpropionic acid
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Dehydrogenase
  • Recptor
    leukotriene C4 (LTC4)
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1074-59-5
  • Formula Weight
    140.1
  • Molecular Formula
    C6H8N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OC(=O)CCc1c[nH]cn1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Munck Af Rosensch?ld M, et al. Discovery of the Oral Leukotriene C4 Synthase Inhibitor (1S,2S)-2-({5-[(5-Chloro-2,4-difluorophenyl)(2-fluoro-2-methylpropyl)amino]-3-methoxypyrazin-2-yl}carbonyl)cyclopropanecarboxylic Acid (AZD9898) as a New Treatment for Asthma. J Med Chem. 2019 Aug 30.
molnova catalog
related products
  • WAY-324168

    WAY-324168 is a compound with antiproliferative activity.

  • CAY10566

    CAY10566 shows excellent cellular activity in blocking the conversion of saturated long-chain fatty acid-CoAs (LCFA-CoAs) to monounsaturated LCFA-CoAs in HepG2 cells (IC50=7.9 nM or 6.8 nM). CAY10566 is a potent, orally bioavailable and selective stearoyl-CoA desaturase1 (SCD1) inhibitor with IC50s of 4.5 and 26 nM in mouse and human enzymatic assays, respectively.

  • Atovaquone

    Atovaquone is a medication used to treat or prevent for pneumocystis pneumonia, toxoplasmosis, malaria, and babesia.